Centene (NYSE:CNC) has outperformed the market over the past 10 years by 2.11% on an annualized basis producing an average annual return of 13.05%. Currently, Centene has a market capitalization of $35.27 billion.
Buying $1000 In CNC: If an ...
Centene (NYSE:CNC) has outperformed the market over the past 10 years by 2.11% on an annualized basis producing an average annual return of 13.05%. Currently, Centene has a market capitalization of $35.27 billion.
Buying $1000 In CNC: If an ...
Market Wire News is a media platform, the information on this page was provided by Benzinga via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Duo Health (“Duo”), a new type of value-based medical group purpose-built to manage chronic kidney disease (CKD) and end-stage kidney disease (ESKD), announced today it has entered into a strategic partnership with Arizona Complete Health, a company that provides and administers hea...
2024-07-11 10:15:04 ET Jefferies analyst issues BUY recommendation for CNC on July 11, 2024 08:47AM ET. The previous analyst recommendation was Buy. CNC was trading at $66.38 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst...
2024-07-11 10:00:10 ET David Windley from Jefferies issued a price target of $83.00 for CNC on 2024-07-11 08:47:00. The adjusted price target was set to $83.00. At the time of the announcement, CNC was trading at $66.38. The overall price target consensus is at $93.53 wi...